Anti-Ceramide ScFv Prophylaxis for First Responders to a Limited Nuclear Attack
While CX-01 prevents GI-ARS lethality, structural modification to extend half-life may be necessary to optimize first responder prophylaxis.
Authors
- Richard Kolesnick (ORCID: https://orcid.org/0000-0002-4914-2945)
- Jin Cheng (ORCID: https://orcid.org/0000-0002-4364-9657)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Cellular Physiology and Biochemistry
- Published
- 2024-08-21
- DOI
- https://doi.org/10.33594/000000721
- Citations
- 2
- Primary Topic
- Effects of Radiation Exposure
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- U.S. Department of Defense
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- U.S. Army Medical Research and Development Command